drugset / Trial / NCT02182687

Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant

NCT02182687 ↗

Phase 2 Completed 60 enrolled Lahey Clinic Varian Medical Systems · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will compare stereotactic body radiation therapy (SBRT) to trans-arterial chemoembolization (TACE) as a bridging strategy for patients with HCC undergoing orthotopic liver transplantation. We propose that SBRT will be associated with longer time intervals between initial treatment and the need for retreatment, compared to TACE, as a "bridge" to orthotopic liver transplantation.

Timeline

Start
2014-06
Primary completion
2021-10
Completion
2021-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxorubin Unknown 100 mg —